Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC prescribing by healthcare practitioners (HCPs) is primarily conducted through the Special Access Scheme - Category B (SAS-B) pathway, through which prescribers apply to...

Full description

Bibliographic Details
Main Authors: Sara L. MacPhail, Miguel A. Bedoya-Pérez, Rhys Cohen, Vicki Kotsirilos, Iain S. McGregor, Elizabeth A. Cairns
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
medicinal cannabis
prescribing trends
Australia
authorised prescriber scheme
special access scheme
cannabinoid
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.885655/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.885655/full

Similar Items